Opus Genetics Inc.
IRD | NASDAQ
$3.67
+$0.02 (+0.55%)
At close: Oct 30, 2026, 4:00 PM ET
$3.73
+$0.06 (+1.63%)
Pre-market:
Nov 2, 2026, 7:31 AM ET
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 |
|---|---|---|---|---|---|---|
PE Ratio | -2.51 | -0.55 | -2.80 | 1.43 | -0.34 | -0.24 |
PEG Ratio | 0.04 | 0 | 0.02 | -0.01 | 0.01 | 0 |
PS Ratio | 88.10 | 2.89 | 1.46 | 0.65 | 32.53 | n/a |
PB Ratio | 81.49 | 4.73 | 0.56 | 0.56 | 0.86 | -0.45 |
P/FCF Ratio | -35.48 | -1.24 | -25.05 | 1.80 | -0.99 | -0.88 |
P/OCF Ratio | -35.48 | -1.24 | -25.05 | 1.80 | -0.99 | -0.88 |
OCF/S Ratio | -248.33 | -232.68 | -5.84 | 35.92 | -3.29K | n/a |
Debt / Equity Ratio | n/a | n/a | n/a | n/a | 0.02 | n/a |
Quick Ratio | 6.43 | 3.24 | 13.35 | 17.79 | 6.76 | 5.55 |
Current Ratio | 6.43 | 3.24 | 13.35 | 17.79 | 6.76 | 5.55 |
Asset Turnover | 0.28 | 0.30 | 0.35 | 0.81 | 0.02 | n/a |
Interest Coverage | -26.33 | n/a | -7.95 | 2.03K | -11.35K | -2.92 |
Return on Equity | -323.11% | -855.62% | -20.01% | 38.69% | -255.12% | 182.82% |
Return on Assets | -98.70% | -156.07% | -18.51% | 36.51% | -217.41% | -139.24% |
Return on Invested Capital | -90.90% | -242.79% | -21.17% | 38.73% | -99.76% | -137.74% |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | 100% | 100% | 100% | 100% | 100% | n/a |
Net Profit Margin | -349.33% | -523.40% | -52.42% | 44.89% | -9.63K% | n/a |
Pretax Profit Margin | -349.33% | -523.40% | -52.36% | 45.68% | -9.63K% | n/a |
Operating Profit Margin | -271.90% | -564.72% | -55.45% | 45.74% | -3.85K% | n/a |
FCF Margin | -248.33% | -232.68% | -5.84% | 35.92% | -3.29K% | n/a |
EBITDA Margin | -338.63% | -523.31% | -52.33% | 45.71% | -9.62K% | n/a |
Add to Watchlist
Select watchlists to add or remove IRD